基本信息
浏览量:11
职业迁徙
个人简介
Intestinal graft-versus-host disease (GVHD) continues to be a significant source of morbidity and mortality after allogeneic stem cell transplantation. Currently, there are no reliable ways to monitor for or predict its occurence before clinical manifestations. Treatment for intestinal GVHD continues to revolve around broad immunosuppression and consequently predisposes patients to signficaint rates of infection. Alpha4beta7 (a4b7) integrin and CCR9 are thought to be two specific mediators of intestinal lymphocyte trafficking, and may present novel targets for the monitoring, prevention, and therapy of intestinal GVHD. Our hypothesis is that a4b7 integrin and CCR9 play essential trafficking roles in the initial allogeneic interaction which leads to intestinal GVHD, and, thus, present novel targets to exploit for monitoring, prevention, and therapeutic applications. Through retrospective and prospective samples, we hope to show that, prior to the onset of actual symptoms, patients have upregulation of both a4b7 integrin and CCR9 expression on subsets of activated T-cells. If this is shown to be true, monitoring these levels may allow pre-emptive therapy to prevent clinically significant morbidity from gut GVHD. In terms of therapy, agents specifically targeted against a4b7 integrin and CCR9, both of which are in development for the treatment of inflammatory bowel disease, will be tested as novel agents for steroid-refractory gut GVHD. The eventual hope will be to include these targeted approaches for prophylaxis as well.
研究兴趣
论文共 63 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
The Lancet Haematologyno. 1 (2022): e14-e25
Leukemia research reports (2022): 100302-100302
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn